ArticlebioRxiv : the preprint server for biology2025
A chemical screen identifies p38 MAPK inhibition as a candidate neuroprotective strategy for combinatorial SMA therapy.
Maria J Carlini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.